Skip to main content
Caplight Logo









CS Pharmaceuticals

CS Pharmaceuticals

Private
LondonHealthcare & Life Scienceshttps://cspharmaceuticals.com/

Last Round

Corporate Funding

Nov 22, 2021

Total Funding Raised

$4.96M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CS Pharmaceuticals is a pharmaceuticals company that develops and commercialises innovative ophthalmology, rare and speciality disease products to address high unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

pharma in-licensingdrug commercializationChina pharma market accessspecialty pharmaophthalmology drugsrare disease drugspharma licensing partnerChina drug regulatorylate-stage drug developmentChina pharma bridgemarket access servicesdry eye disease treatmentMeibomian Gland Dysfunctionidiopathic pulmonary fibrosiscystic fibrosis treatmentNational Reimbursement Drug ListNRDL

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CS Pharmaceuticals Comparables

Compare CS Pharmaceuticals with similar companies based on industry and business-model similarity.

CS Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sperogenix Therapeutics
79%
Arctic Vision
71%
Hasten Biopharmaceutical Co., Ltd.
66%
View all Comparables

CS Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 22, 2021
SeedJun 1, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Darren Mercer

Chief Executive Officer

Executive Team

CS Pharmaceuticals Investors

Notable investors and investment history

CS Pharmaceuticals investors
InvestorRounds
Downing VenturesCorporate Funding
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 368% MoM, from 235 to 1.1K.

  • May 17, 2026

    Monthly visitors increased 36% MoM, from 803 to 1.1K.

View all signals

CS Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CS Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CS Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range4
Year Founded2020
Last FundingNov 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?